Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer

Internal Medicine

Volumn 44, Issue 9, 2005, Pages 979-982

  Umemura, Shigeki ^a   Kishino, Daizo ^b   Tabata, Masahiro ^a   Kiura, Katsuyuki ^a   Hotta, Katsuyuki ^a   Nishii, Kenji ^b   Tanimoto, Yasushi ^a   Kanehiro, Arihiko ^a   Notohara, Kenji ^a   Ueoka, Hiroshi ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Southern Institute of Health   (Japan)

Author keywords

Gefitinib; Ground glass opacity; NSCLC; Transbronchial lung biopsy; Tumor embolism

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEFITINIB; IRINOTECAN; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; BRAIN INFARCTION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; INTERSTITIAL LUNG DISEASE; KIDNEY INFARCTION; LUNG ADENOCARCINOMA; LUNG BLOOD VESSEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SPLEEN INFARCTION; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TUMOR CELL; TUMOR EMBOLISM;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; QUINAZOLINES;

EID: 27844452453     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.979     Document Type: Article

References (20)

1. Arteaga CL, Johnson DH. Tyrosine kinase inhibitors-ZD1839 (IRESSA). Curr Opin Oncol 13: 491-498, 2001.
2. Baselga J, Rischin D, Ranson M, et al. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol 20: 4292-4302, 2002.
3. Ranson M, Hammond LA, Ferry D, et al. ZD1939, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. J Clin Oncol 20: 2240-2250, 2002.
4. Herbst RS, Maddox AM, Rothenberg ML, et al. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial. J Clin Oncol 20: 3815-3825, 2002.
5. Inoue A, Saijo Y, Maemondo M, et al. Severe acute interstitial pneumonia and gefitinib. The Lancet 361: 137-139, 2003.
6. Takano T, Ohe Y, Kusumoto M, et al. Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib. Lung Cancer 45: 93-104, 2004.
7. Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839) (IRESSA) tablets. Oncologist 8: 303-306, 2003.
8. Okamoto I, Fujii K, Matsumoto M, et al. Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer. Lung Cancer 40: 339-342, 2003.
9. Lefkovitz NW, Roessmann U, Kori SH. Major cerebral infarction from tumor embolus. Stroke 17: 555-557, 1986.
10. Schneiderman J, Lieberman Y, Adar R. Multiple tumor emboli after lung resection. J Cardiovasc Surg (Torino) 30: 496-498, 1989.
11. Chandler C. Malignant arterial tumor embolization. J Surg Oncol 52: 197-202, 1993.
12. Aylwin JA. Avoidable vascular spread in resection for bronchial carcinoma. Thorax 6: 250-267, 1951.
13. Bollen EC, Van Duin CJ, Van Noord JA, Janssen JG, Theunissen PH. Tumor embolus in lung surgery. A case report and review of the literature. Eur J Cardiothorac Surg 7: 104-106, 1993.
14. Morasch MD, Shanik GD. Tumor embolus: a case report and review of the literature. Ann Vasc Surg 17: 210-213, 2003.
15. Al-Thenayan E, Maghfoor I. Systemic tumor embolism from lung cancer at presentation. J Clin Oncol 22: 372-373, 2004.
16. Balas P, Katsaras E, Ziotopopoulos M. Peripheral arterial embolism by malignant tumor. Vasc Surg 5: 27-29, 1971.
17. Whyte RI, Starkey TD, Orringer MB. Tumor emboli from lung neoplasms involving pulmonary vein. J Thorac Cardiovasc Surg 104: 421-425, 1992.
18. Hansell DM. Small-vessel diseases of the lung. CT-pathologic correlates. Radiology 225: 639-653, 2002.
19. Rossi SE, Erasmus FF, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiograhics 20: 1245-1259, 2000.
20. Miya, T, Ono Y, Tanaka H, Koshiishi Y, Goya T. Radiation recall pneumonitis induced by Gefitinib (Iressa): A case report. Nihon Kokyuki Gakkai Zasshi 41: 565-568, 2003 (in Japanese).